Arterial thrombi and atherosclerotic lesions were analyzed immunochemically and
examined histologically. The extent of in vivo proteolytic cleavage of the amino-terminal end …

Soluble fibrin/fibrinogen-related antigens and insoluble fibrin are present in virtually all
samples of human aortic intima. Components of the soluble fraction were identified by SDS …

Samples of normal and atherosclerotic vessels obtained from vascular and cardiothoracic
surgery were examined for the distribution of fibrinogen/fibrin I, fibrin II, and fibrin (ogen) …

Fibrinogen and fibrinogen/fibrin-related antigen (total FRA) was measured in human normal
intima and different types of atherosclerotic lesions and mural thrombi. The amount showed …

A quantitative assay for fibrin or other insoluble fibrin-like antigens (“fibrin”) in small samples
of intima is described. Tissue samples were subjected to electrophoresis directly from the …

Immunohistochemical studies of human atherosclerotic lesions have demonstrated the
occurrence of fibrin deposition and its degradation in the arterial wall. We studied fibrinogen …

High plasma fibrinogen appears to be an important risk factor for the development of
atherosclerosis. The aim of our study was to measure fibrinogen and fibrin degradation …

A new method is described for identifying low concentrations of circulating derivatives of
fibrinogen and fibrin, even when present in heterogeneous mixtures. This technique is …

Circulating soluble fibrin, observed in the blood of patients with ongoing intravascular
coagulation, is generated from the plasma protein fibrinogen by the limited proteolytic action …

Among the various theories of atherogenesis the interrelationship between atherosclerosis
and thrombosis has long been controversial because the final event, it., presence of thrombi …